Extending preimplantation genetic diagnosis: medical and non-medical uses
Robertson, John A.
Journal of Medical Ethics 2003 August; 29(4): 213-216
New uses of preimplantation genetic diagnosis (PGD) to screen embryos prior to transfer raise ethical, legal, and policy issues that deserve close attention. Extensions for medical purposes, such as to identify susceptibility genes, late onset disease, and human leukocyte antigen (HLA) matching, are usually ethically acceptable. Whether embryo screening for gender, perfect pitch, or other non-medical characteristics are also acceptable depends upon the parental needs served and the harm posed to embryos, children, and society. Speculations about potential future uses of PGD should not prevent otherwise acceptable current uses of PGD.
Showing items related by title, author, creator and subject.
Bach to the future: response to: Extending preimplantation genetic diagnosis: medical and non-medical uses Ashcroft, Richard E. (2003-08)Professor Robertson sketches an elegant framework for policy evaluation and regulation of the use of preimplantation genetic diagnosis for various medical, medical related, and non-medical purposes. In criticism of his ...
Robertson, John A. (2003-03)
Robertson, John A. (2005-03)